Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
PG Pappas, CMF Rotstein, RF Betts… - Clinical infectious …, 2007 - academic.oup.com
Background. Invasive candidiasis is an important cause of morbidity and mortality among
patients with health care–associated infection. The echinocandins have potent fungicidal
activity against most Candida species, but there are few data comparing the safety and
efficacy of echinocandins in the treatment of invasive candidiasis. Methods. This was an
international, randomized, double-blind trial comparing micafungin (100 mg daily) and
micafungin (150 mg daily) with a standard dosage of caspofungin (70 mg followed by 50 mg …
patients with health care–associated infection. The echinocandins have potent fungicidal
activity against most Candida species, but there are few data comparing the safety and
efficacy of echinocandins in the treatment of invasive candidiasis. Methods. This was an
international, randomized, double-blind trial comparing micafungin (100 mg daily) and
micafungin (150 mg daily) with a standard dosage of caspofungin (70 mg followed by 50 mg …
[引用][C] Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (vol 45, pg 883, 2007)
PG Pappas, CMF Rotstein, RF Betts… - Clinical Infectious …, 2008 - biblio.ugent.be
Author PG PAPPAS, CMF ROTSTEIN, RF BETTS, M NUCCI, D TALWAR, Jan De Waele, JA
VAZQUEZ, BF DUPONT, DL HORN, L OSTROSKY-ZEICHNER, AC REBOLI, B SUH, R
DIGUMARTI, C WU, LL KOVANDA, LJ ARNOLD and DN BUELL
VAZQUEZ, BF DUPONT, DL HORN, L OSTROSKY-ZEICHNER, AC REBOLI, B SUH, R
DIGUMARTI, C WU, LL KOVANDA, LJ ARNOLD and DN BUELL
以上显示的是最相近的搜索结果。 查看全部搜索结果